메뉴 건너뛰기




Volumn 7, Issue , 2015, Pages 273-280

Adherence to statin treatment following a myocardial infarction: An Italian population-based survey

(12)  Monaldi, Bruno a   Bologna, Giovanni b   Costa, Geeta Giulia c   D’Agostino, Carlo d   Ferrante, Fulvio e   Filice, Maurizio f   Grion, Anna Maria g   Mingarelli, Alessandra h   Paloscia, Leonardo i   Tettamanti, Roberto j   Veronesi, Chiara k   Esposti, Luca Degli k  


Author keywords

Adherence to treatment; Discontinuation; Myocardial infarction; Statins

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

EID: 84930675539     PISSN: None     EISSN: 11786981     Source Type: Journal    
DOI: 10.2147/CEOR.S70936     Document Type: Article
Times cited : (14)

References (30)
  • 1
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • [No authors listed]
    • [No authors listed]. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–1389.
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 2
    • 0037140177 scopus 로고    scopus 로고
    • Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentra­tions: The LIPID trial follow-up
    • )
    • LIPID Study Group (Long-term Intervention with Pravastatin in Ischae­mic Disease). Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentra­tions: the LIPID trial follow-up. Lancet. 2002;359:1379–1387.
    • (2002) Lancet , vol.359 , pp. 1379-1387
  • 3
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals; a randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals; a randomised placebo-controlled trial. Lancet. 2002;360:7–22.
    • (2002) Lancet , vol.360 , pp. 7-22
  • 4
    • 15944410609 scopus 로고    scopus 로고
    • Intensive lipid lowering with atorvastatin in patients with stable coronary disease
    • LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425–1435.
    • (2005) N Engl J Med , vol.352 , pp. 1425-1435
    • Larosa, J.C.1    Grundy, S.M.2    Waters, D.D.3
  • 5
    • 0035804846 scopus 로고    scopus 로고
    • Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial
    • Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285:1711–1718.
    • (2001) JAMA , vol.285 , pp. 1711-1718
    • Schwartz, G.G.1    Olsson, A.G.2    Ezekowitz, M.D.3
  • 6
    • 0035897696 scopus 로고    scopus 로고
    • Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
    • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497.
    • (2001) JAMA , vol.285 , pp. 2486-2497
  • 7
    • 0042512336 scopus 로고    scopus 로고
    • European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovas­cular Disease Prevention in Clinical Practice
    • De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovas­cular Disease Prevention in Clinical Practice. Eur Heart J. 2003;24:1601–1610.
    • (2003) Eur Heart J , vol.24 , pp. 1601-1610
    • De Backer, G.1    Ambrosioni, E.2    Borch-Johnsen, K.3
  • 8
    • 33744982042 scopus 로고    scopus 로고
    • AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute
    • Smith SC, Allen J, Blair S, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113:2363–2372.
    • (2006) Circulation , vol.113 , pp. 2363-2372
    • Smith, S.C.1    Allen, J.2    Blair, S.3
  • 9
    • 0003585866 scopus 로고    scopus 로고
    • Washington: NCQA
    • National Committee for Quality Assurance. The State of Managed Care Quality. Washington: NCQA; 1999.
    • (1999) The State of Managed Care Quality
  • 10
    • 40949131340 scopus 로고    scopus 로고
    • Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease
    • Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155:722–729.
    • (2008) Am Heart J , vol.155 , pp. 722-729
    • Ho, P.M.1    Magid, D.J.2    Shetterly, S.M.3
  • 11
    • 70349515344 scopus 로고    scopus 로고
    • Long-term medication adherence after myocardial infarction: Experience of a community
    • Shah ND, Dunlay SM, Ting HH, et al. Long-term medication adherence after myocardial infarction: experience of a community. Am J Med. 2009;122:e7–e13.
    • (2009) Am J Med , vol.122
    • Shah, N.D.1    Dunlay, S.M.2    Ting, H.H.3
  • 12
    • 27644432342 scopus 로고    scopus 로고
    • Guideline-based standardized care is associated with substantially lower mortality in Medicare patients with acute myocardial infarction: The American College of Cardiology’s Guidelines Applied in Practice (GAP) Projects in Michigan
    • Eagle KA, Montoye CK, Riba AL, et al. Guideline-based standardized care is associated with substantially lower mortality in Medicare patients with acute myocardial infarction: the American College of Cardiology’s Guidelines Applied in Practice (GAP) Projects in Michigan. J Am Coll Cardiol. 2005;46:1242–1248.
    • (2005) J am Coll Cardiol , vol.46 , pp. 1242-1248
    • Eagle, K.A.1    Montoye, C.K.2    Riba, A.L.3
  • 13
    • 0035253035 scopus 로고    scopus 로고
    • Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality
    • Muhlestein JB, Horne BD, Bair TL, et al. Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol. 2001;87:257–261.
    • (2001) Am J Cardiol , vol.87 , pp. 257-261
    • Muhlestein, J.B.1    Horne, B.D.2    Bair, T.L.3
  • 14
    • 75649115762 scopus 로고    scopus 로고
    • Prognostic stratification of folder persons based on simple administrative data: Development and valida­tion of the “Silver Code,” to be used in emergency department triage
    • Di Bari M, Balzi D, Roberts AT, et al. Prognostic stratification of folder persons based on simple administrative data: development and valida­tion of the “Silver Code,” to be used in emergency department triage. J Gerontol A Biol Sci Med Sci. 2010;65:159–164.
    • (2010) J Gerontol a Biol Sci Med Sci , vol.65 , pp. 159-164
    • Di Bari, M.1    Balzi, D.2    Roberts, A.T.3
  • 15
    • 80054733989 scopus 로고    scopus 로고
    • Ministero del Lavoro, della Salute e delle Politiche Sociali, Accessed April 24, 2009
    • Ministero del Lavoro, della Salute e delle Politiche Sociali. Rapporto annuale sulle attivita’ di ricovero ospedaliero. 2005. Available from: http://www.salute.gov.it/. Accessed April 24, 2009.
    • (2005) Rapporto Annuale Sulle attivita’ Di Ricovero Ospedaliero
  • 17
    • 0034515494 scopus 로고    scopus 로고
    • Predictors of long-term persistence on statins in a subsidized clinical population
    • Catalan VS, LeLorier J. Predictors of long-term persistence on statins in a subsidized clinical population. Value Health. 2000;3:417–426.
    • (2000) Value Health , vol.3 , pp. 417-426
    • Catalan, V.S.1    Lelorier, J.2
  • 18
    • 0036720351 scopus 로고    scopus 로고
    • Adherence to statin treatment and readmission of patients after myocar­dial infarction: A six year follow up study
    • Wei L, Wang J, Thompson P, Wong S, Struthers AD, MacDonald TM. Adherence to statin treatment and readmission of patients after myocar­dial infarction: a six year follow up study. Heart. 2002;88:229–233.
    • (2002) Heart , vol.88 , pp. 229-233
    • Wei, L.1    Wang, J.2    Thompson, P.3    Wong, S.4    Struthers, A.D.5    Macdonald, T.M.6
  • 19
    • 0037085951 scopus 로고    scopus 로고
    • Underuse of aspirin in a referral population with documented coronary artery disease
    • Califf RM, DeLong E, Ostbyte T, et al. Underuse of aspirin in a referral population with documented coronary artery disease. Am J Cardiol. 2002;89:653–661.
    • (2002) Am J Cardiol , vol.89 , pp. 653-661
    • Califf, R.M.1    Delong, E.2    Ostbyte, T.3
  • 20
    • 33645013643 scopus 로고    scopus 로고
    • Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease
    • Newby LK, LaPointe NM, Chen AY, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113:203–212.
    • (2006) Circulation , vol.113 , pp. 203-212
    • Newby, L.K.1    Lapointe, N.M.2    Chen, A.Y.3
  • 21
    • 0037070528 scopus 로고    scopus 로고
    • Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative
    • Mehta RH, Montoye CK, Gallogly M, et al. Improving quality of care for acute myocardial infarction: the Guidelines Applied in Practice (GAP) Initiative. JAMA. 2002;287:1269–1276.
    • (2002) JAMA , vol.287 , pp. 1269-1276
    • Mehta, R.H.1    Montoye, C.K.2    Gallogly, M.3
  • 23
    • 33644513067 scopus 로고    scopus 로고
    • Statin wars following coronary revascularization – evidence-based clinical practice?
    • Brophy JM, Costa V. Statin wars following coronary revascularization – evidence-based clinical practice? Can J Cardiol. 2006;22:54–58.
    • (2006) Can J Cardiol , vol.22 , pp. 54-58
    • Brophy, J.M.1    Costa, V.2
  • 24
    • 0035313265 scopus 로고    scopus 로고
    • Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)
    • Fonarow GC, Gawlinski A, Moughrabi S, Tillisch JH. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol. 2001;87:819–822.
    • (2001) Am J Cardiol , vol.87 , pp. 819-822
    • Fonarow, G.C.1    Gawlinski, A.2    Moughrabi, S.3    Tillisch, J.H.4
  • 25
    • 0037348973 scopus 로고    scopus 로고
    • Drug pre­scriptions after acute myocardial infarction: Dosage, compliance, and persistence
    • Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L. Drug pre­scriptions after acute myocardial infarction: dosage, compliance, and persistence. Am Heart J. 2003;145:438–444.
    • (2003) Am Heart J , vol.145 , pp. 438-444
    • Simpson, E.1    Beck, C.2    Richard, H.3    Eisenberg, M.J.4    Pilote, L.5
  • 26
    • 6944240055 scopus 로고    scopus 로고
    • Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: National Registry of Myocardial Infarction
    • Spencer FA, Fonarow GC, Frederick PD, et al. Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: National Registry of Myocardial Infarction. Arch Intern Med. 2004;164:2162–2168.
    • (2004) Arch Intern Med , vol.164 , pp. 2162-2168
    • Spencer, F.A.1    Fonarow, G.C.2    Frederick, P.D.3
  • 27
    • 0037167013 scopus 로고    scopus 로고
    • Adherence with statin therapy in elderly patients with and without acute coronary syndromes
    • Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288:462–467.
    • (2002) JAMA , vol.288 , pp. 462-467
    • Jackevicius, C.A.1    Mamdani, M.2    Tu, J.V.3
  • 29
    • 78449281377 scopus 로고    scopus 로고
    • Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials
    • Cholesterol Treatment Trialists (CTT) Collaboration, Baigent C, Blackwell L, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376:1670–1681.
    • (2010) Lancet , vol.376 , pp. 1670-1681
    • Baigent, C.1    Blackwell, L.2
  • 30
    • 50849088669 scopus 로고    scopus 로고
    • Discontinuation of statin therapy following an acute myo­cardial infarction: A population-based study
    • Daskalopoulou SS, Delaney JA, Filion KB, Brophy JM, Mayo NE, Suissa S. Discontinuation of statin therapy following an acute myo­cardial infarction: a population-based study. Eur Heart J. 2008;29: 2083–2091.
    • (2008) Eur Heart J , vol.29 , pp. 2083-2091
    • Daskalopoulou, S.S.1    Delaney, J.A.2    Filion, K.B.3    Brophy, J.M.4    Mayo, N.E.5    Suissa, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.